IMC-Chicago »

Moonlake Immunotherapeutics shares owned by IMC-Chicago

Quarter-by-quarter ownership of Moonlake Immunotherapeutics shares owned by IMC-Chicago from 13F filings

Historical chart of IMC-Chicago investment in Moonlake Immunotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunotherapeutics held by IMC-Chicago consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunotherapeutics by IMC-Chicago

Quarter filed Position value Share count Share price at filing
2025-12-31 $488k 37k 13.18

More positions owned by IMC-Chicago

Spdr S&p 500 Etf Tr Tr Unit Put Option
Spdr S&p 500 Etf Tr Tr Unit Call Option
Tesla Motors Inc cmn Call Option
Nvidia Corp option Call Option
Nvidia Corp option Put Option
Tesla Motors Inc cmn Put Option
Invesco Qqq Tr Unit Ser 1 Put Option
Invesco Qqq Tr Unit Ser 1 Call Option
Meta Platforms Cl A Call Option
Apple Inc option Call Option
Meta Platforms Cl A Put Option
Alphabet Cap Stk Cl A Call Option
Apple Inc option Put Option
Microsoft Corp Call Option
Broadcom Inc put Put Option

View all positions for IMC-Chicago

Top funds holding Moonlake Immunotherapeutics

Simplex Trading
Group One Trading
IMC-Chicago

View all funds holding Moonlake Immunotherapeutics